Nothing Special   »   [go: up one dir, main page]

NO870027D0 - Ekspresjon av htlv-iii gag-gen. - Google Patents

Ekspresjon av htlv-iii gag-gen.

Info

Publication number
NO870027D0
NO870027D0 NO870027A NO870027A NO870027D0 NO 870027 D0 NO870027 D0 NO 870027D0 NO 870027 A NO870027 A NO 870027A NO 870027 A NO870027 A NO 870027A NO 870027 D0 NO870027 D0 NO 870027D0
Authority
NO
Norway
Prior art keywords
htlv
expression
iii gag
gen
gag gen
Prior art date
Application number
NO870027A
Other languages
English (en)
Other versions
NO870027L (no
Inventor
Richard Kramer
Premkumar Reddy
Michael Shaber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO870027D0 publication Critical patent/NO870027D0/no
Publication of NO870027L publication Critical patent/NO870027L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO870027A 1986-01-06 1987-01-05 Ekspresjon av htlv-iii gag-gen. NO870027L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81664586A 1986-01-06 1986-01-06

Publications (2)

Publication Number Publication Date
NO870027D0 true NO870027D0 (no) 1987-01-05
NO870027L NO870027L (no) 1987-07-07

Family

ID=25221244

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870027A NO870027L (no) 1986-01-06 1987-01-05 Ekspresjon av htlv-iii gag-gen.

Country Status (5)

Country Link
EP (1) EP0230222A1 (no)
JP (1) JPS62164696A (no)
AU (1) AU6713287A (no)
DK (1) DK3687A (no)
NO (1) NO870027L (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860915B (en) * 1985-04-08 1986-07-11 Genetic Systems Corp Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
FR2625100A2 (fr) * 1986-03-13 1989-06-30 Lurhuma Zirimwabagabo Utilisation d'antigenes pour la preparation de vaccins, proteine rendue immunogene et composition pharmaceutique la comportant
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
US4983387A (en) * 1986-05-19 1991-01-08 Viral Technologies Inc. HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
DK643188A (da) * 1987-11-24 1989-05-25 Smithkline Biolog Ekspression af hiv-proteiner i e.coli og s.cerevisiae
JPH01148183A (ja) * 1987-12-04 1989-06-09 Hiroshi Shibuta 組み換えワクチニアウイルス
IL89993A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of the hiv 24kda gag protein in methylotrophic yeasts
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
GB2220939B (en) * 1988-06-10 1992-02-26 Medical Res Council Peptide fragments of hiv and their use in vaccines and diagnosis
EP0352060A3 (en) * 1988-07-21 1990-12-27 Takeda Chemical Industries, Ltd. Expression plasmid and use thereof
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
JP3058685B2 (ja) * 1989-05-08 2000-07-04 アイデックス ラボラトリーズ インコーポレーテッド ネコｔ細胞リンパトロピック レンチウィルスのポリペプチド
JPH03128393A (ja) * 1989-05-17 1991-05-31 Sangstat Medical Corp ヒトリンパ栄養性ウィルスの処理及び診断
GB8918200D0 (en) * 1989-08-09 1989-09-20 Medical Res Council The peptide fragments of hiv
IL95738A (en) * 1989-09-23 1996-11-14 Hoechst Ag Antibodies against the well-preserved amino acid sequences of insulin, a process for their preparation and use in immunoassay
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
EP0510054A1 (en) * 1990-01-05 1992-10-28 United Biomedical, Inc. Hiv-1 core protein fragments
HUT62654A (en) * 1990-05-28 1993-05-28 Univ Osaka Res Found Process for producing plasmid capable of expressing retrovirus gene and processing it after translation, as well its expression products
AU8849391A (en) * 1990-08-16 1992-03-17 Diagnostic Biotechnology, Inc. An augmented western blot format and immunoassay for detection of viral antibodies
JPH08510756A (ja) 1993-06-04 1996-11-12 ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ ストレス蛋白質とその使用
US6525173B1 (en) * 1997-01-02 2003-02-25 Universidade Federal De Minas Gerais Process for expression and production of recombinant protein hybrid protein (p24/p17) derived from human immunodeficiency viruses (HIV-1)
WO1999012416A1 (en) * 1997-09-09 1999-03-18 The Trustees Of Columbia University In The City Of New York T-independent conjugate-vaccines
US5972339A (en) * 1997-11-13 1999-10-26 The General Hospital Corporation Method of eliciting anti-HIV-1 helper T cell responses
NO311807B1 (no) 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
US6964851B2 (en) 1999-12-07 2005-11-15 Stressgen Biotechnologies Corp. Compositions and methods for detecting stress-inducible proteins
WO2001051081A1 (en) 2000-01-14 2001-07-19 Whitehead Institute For Biomedical Research In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
AU2001271449B2 (en) 2000-06-26 2006-08-24 Nventa Biopharmaceuticals Corporation Human papilloma virus treatment
JP2015520179A (ja) 2012-06-06 2015-07-16 ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ ワクチン
US20170165321A1 (en) 2014-07-11 2017-06-15 Bionor Immuno As Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
DE3588134T2 (de) * 1984-12-24 1997-03-20 Genentech Inc Fusionen von AIDS-verwandten Polypeptiden

Also Published As

Publication number Publication date
NO870027L (no) 1987-07-07
AU6713287A (en) 1987-07-09
DK3687A (da) 1987-07-07
JPS62164696A (ja) 1987-07-21
DK3687D0 (da) 1987-01-05
EP0230222A1 (en) 1987-07-29

Similar Documents

Publication Publication Date Title
NO870027D0 (no) Ekspresjon av htlv-iii gag-gen.
FI875395A (fi) Substituerade basiska 2-aminotetraliner.
FI881022A0 (fi) Korrigering av funktionsodugliga venklaffar.
DE3780933D1 (de) Herstellung von aminoalanen.
NO875487D0 (no) Fremgangsmaate for selektiv behandling av en undergrunnsformasjon.
FI872367A (fi) Foerfarande foer framstaellning av vattenhaltiga n-metylmorfolin-n-oxidloesningar.
NO871939L (no) Fremgangsmaate for oeket ekspresjon av interleukin-2.
ES2015047B3 (es) Nuevos derivados de 18-fenilestrano.
DE3851366D1 (de) Digitaler Generator von Konturlinien.
FI870170A0 (fi) Vaermestabila finfoerdelade artificiella soetningsmedel.
NO870409L (no) Fremgangsmaate for spaltning av 1-aminoindaner.
FI873707A (fi) Nya, -substituerade ketonitronderivat.
NO870829L (no) Immortalisering av primŸrceller.
DE3761048D1 (de) Umsetzungsprodukte von bis-glycidylthioethern.
NO872255D0 (no) Fremgangsmaate for dekaffinering av raakaffe.
ES2023930B3 (es) Sintesis de ditioles.
NO165919C (no) Fremgangsmaate for ekstraksjon av parafiner.
ES2016570B3 (es) Derivados fluorados de diaminoalquinos.
NO870828D0 (no) Fremgangsmaate for fremstilling av biskarbamater.
NO884674L (no) Bleking av tremasse.
FI871616A0 (fi) Foerfarande foer framstaellning av n-(sulfonylmetyl)formamider.
NO871721D0 (no) Fremgangsmaate for fremstilling av ergolenderivater.
DE3766873D1 (de) Herstellung von substituierten dichlormethylpyridinen.
FI872806A (fi) Foerfarande foer framstaellning av hydrerade 1-fenoxialkylpyridin-3-karboxylsyrafoereningar.
DE3773666D1 (de) Herstellung von n-epoxypropyl-lactamen.